HIGHPASS BIO Trademark

Trademark Overview


On Sunday, November 25, 2018, a trademark application was filed for HIGHPASS BIO with the United States Patent and Trademark Office. The USPTO has given the HIGHPASS BIO trademark a serial number of 88204562. The federal status of this trademark filing is REGISTERED as of Tuesday, September 13, 2022. This trademark is owned by ElevateBio, LLC. The HIGHPASS BIO trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical products development; Research and development in the field of oncology; Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research and development of vaccines and medicines; Research and development services in the field of antibodies; Research in the field of oncology; Research on the subject of pharmaceuticals; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Bacteriological research; Biochemical research and development; Biological research; Biomedical research services; Biotechnology research; Chemical, biochemical, biological and bacteriological research and analysis; Clinical research in the field of oncology; Compiling data for research purposes in the field of medical science and medical consultancy; Consulting services in the fields of biotechnology, pharmaceutical research and devel...
highpass bio

General Information


Serial Number88204562
Word MarkHIGHPASS BIO
Filing DateSunday, November 25, 2018
Status700 - REGISTERED
Status DateTuesday, September 13, 2022
Registration Number6846903
Registration DateTuesday, September 13, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 14, 2019

Trademark Statements


Pseudo MarkHIGH PASS BIOTECHNOLOGY; HIGH PASS BIOCHEMICAL
Disclaimer with Predetermined Text"BIO"
Goods and ServicesPharmaceutical products development; Research and development in the field of oncology; Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research and development of vaccines and medicines; Research and development services in the field of antibodies; Research in the field of oncology; Research on the subject of pharmaceuticals; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Bacteriological research; Biochemical research and development; Biological research; Biomedical research services; Biotechnology research; Chemical, biochemical, biological and bacteriological research and analysis; Clinical research in the field of oncology; Compiling data for research purposes in the field of medical science and medical consultancy; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Development of pharmaceutical preparations and medicines; Laboratory research in the field of oncology; Laboratory research services relating to pharmaceuticals; Medical research; Medical and scientific research in the field of oncology; Medical and scientific research information in the field of cancer; Medical and scientific research in the field of cancer treatment and diagnosis; Medical research services in the field of cancer; Pharmaceutical research and development; Pharmaceutical research services; Providing laboratory research services in the field of gene expression, namely, cancer biology; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Providing medical research and scientific research information in the field of oncology via the Internet; Providing medical testing services and information in the field of cancer research and disease classification; Scientific research; Scientific research and development; Scientific research consulting in the field of oncology; Scientific research for medical purposes in the area of cancerous diseases; Scientific research for medical purposes in the field of cancer; Stem cell research services; Technical research in the field of pharmaceutical studies; Testing of pharmaceuticals; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, December 13, 2018
Primary Code042
First Use Anywhere DateSaturday, October 19, 2019
First Use In Commerce DateSaturday, October 19, 2019

Trademark Owner History


Party NameElevateBio, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressCambridge, MA 02142

Party NameElevateBio, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressCambridge, MA 02142

Party NameElevateBio, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressCambridge, MA 02142

Trademark Events


Event DateEvent Description
Tuesday, September 13, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, September 13, 2022REGISTERED-PRINCIPAL REGISTER
Wednesday, August 10, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, August 9, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, July 8, 2022STATEMENT OF USE PROCESSING COMPLETE
Tuesday, July 5, 2022USE AMENDMENT FILED
Tuesday, July 5, 2022TEAS STATEMENT OF USE RECEIVED
Saturday, January 8, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, January 7, 2022SOU EXTENSION 5 GRANTED
Tuesday, January 4, 2022SOU EXTENSION 5 FILED
Tuesday, January 4, 2022TEAS EXTENSION RECEIVED
Wednesday, July 7, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 5, 2021SOU EXTENSION 4 GRANTED
Monday, July 5, 2021SOU EXTENSION 4 FILED
Monday, July 5, 2021TEAS EXTENSION RECEIVED
Thursday, June 10, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, June 10, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, June 10, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, February 23, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 22, 2021SOU EXTENSION 3 GRANTED
Monday, January 11, 2021SOU EXTENSION 3 FILED
Wednesday, February 17, 2021NOTICE OF REVIVAL - E-MAILED
Tuesday, February 16, 2021EXTENSION RECEIVED WITH TEAS PETITION
Tuesday, February 16, 2021PETITION TO REVIVE-GRANTED
Tuesday, February 16, 2021TEAS PETITION TO REVIVE RECEIVED
Tuesday, February 16, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, February 15, 2021ABANDONMENT - NO USE STATEMENT FILED
Friday, August 14, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 13, 2020SOU EXTENSION 2 GRANTED
Thursday, July 9, 2020SOU EXTENSION 2 FILED
Tuesday, August 11, 2020NOTICE OF REVIVAL - E-MAILED
Monday, August 10, 2020EXTENSION RECEIVED WITH TEAS PETITION
Monday, August 10, 2020PETITION TO REVIVE-GRANTED
Monday, August 10, 2020TEAS PETITION TO REVIVE RECEIVED
Monday, August 10, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, August 10, 2020ABANDONMENT - NO USE STATEMENT FILED
Friday, March 27, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 26, 2020SOU EXTENSION 1 GRANTED
Thursday, January 9, 2020SOU EXTENSION 1 FILED
Wednesday, March 25, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, March 2, 2020NOTICE OF REVIVAL - E-MAILED
Saturday, February 29, 2020EXTENSION RECEIVED WITH TEAS PETITION
Saturday, February 29, 2020PETITION TO REVIVE-GRANTED
Saturday, February 29, 2020TEAS PETITION TO REVIVE RECEIVED
Monday, February 10, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, February 10, 2020ABANDONMENT - NO USE STATEMENT FILED
Monday, July 22, 2019ASSIGNED TO EXAMINER
Tuesday, July 9, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 14, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 14, 2019PUBLISHED FOR OPPOSITION
Wednesday, April 24, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, April 11, 2019LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, April 11, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, February 25, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, February 25, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, February 11, 2019ASSIGNED TO LIE
Wednesday, February 6, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, February 4, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, February 4, 2019NON-FINAL ACTION E-MAILED
Monday, February 4, 2019NON-FINAL ACTION WRITTEN
Monday, January 28, 2019ASSIGNED TO EXAMINER
Thursday, December 13, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Wednesday, November 28, 2018NEW APPLICATION ENTERED IN TRAM